LyphoMed Inc said intends file registration statement Securities Exchange Commission covering sale 70 mln dlrs principal amount convertible subordinated debenture .
Concurrent debenture offering , LyphoMed said plan sell additional 30 mln dlrs debenture Fujisawa Pharmaceutical Co Ltd , currently owns 30 pct company 's common stock .
It said offering made prospectus .
Reuter & # 3 ; 